Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03870698
Other study ID # CORLAPPD_01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 9, 2019
Est. completion date August 31, 2022

Study information

Verified date February 2023
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Laparoscopic surgery has not changed much in safety compared with open surgery through many existing studies, and has become a procedure to help patients' recovery. Recently, laparoscopic surgery has been actively performed for pancreaticoduodenectomy, one of the most complicated procedures in intraperitoneal surgery. the investigators will perform a prospective study to establish a higher level of evidence for the efficacy and safety of laparoscopic pancreaticoduodenectomy. The purpose of this study was to compare the short-term clinical outcomes including the functional recovery after surgery, complications and confirm that laparoscopic pancreaticoduodenectomy is safe and appropriate. This study includes an interim analysis and can be terminated early by analysis at the completion of 50% of planned patients.


Description:

- Pancreatoduodenectomy is a standard procedure for periampullary disease of the duodenum (pancreatic cancer, biliary pancreatic cancer, bile duct cancer, etc.) and is a very extensive and complicated operation for partial resection of the pancreas, duodenum, bile duct, gallbladder and occasionally stomach. In addition, anastomotic anastomoses are considered to be one of the most complicated surgeries among intraperitoneal procedures, even in open surgery. Laparoscopic surgery has been advancing rapidly with the development of the technique of laparoscopic surgery. In recent years, Pancreatoduodenectomy has been actively attempting laparoscopic surgery centering on large organs. As a result, large incision and abdominal wall traction can be avoided. Common advantages include postoperative pain relief, rapid recovery of bowel movements, fewer days of hospitalization, and a quick return to daily life. In addition, recently reported meta-analysis has shown that laparoscopic Pancreatoduodenectomy has a significantly lower bleeding volume and duration of hospitalization compared to open surgery. - This study was aimed to compared functional recovery between open and laparoscopic PD in 3 tertiary referral centers in Korea. The investigators will measure functional recovery . - A case of pancreaticoduodenectomy with benign tumor in the pancreas will be included. The expected number of patients is 252. The laparoscopic surgery was performed in the experimental group and the open surgery was performed in the control group. When achieving 50% of the planned target group, the interim analysis will decide whether to continue the study. This clinical study is a randomized prospective comparative study of the outcome of laparoscopic and open Pancreatoduodenectomy, and the research hypothesis is as follows. - Nursing Hypothesis: There is no difference in the functional recovery between patients who underwent laparoscopic pancreaticoduodenectomy and patients who underwent open surgery. - Alternative Hypothesis: Based on the results of the same operation of the existing institution, the average functional recovery for open pancreaticoduodenectomy is estimated to be 14 days, and the functional recovery for laparoscopic pancreaticoduodenectomy is reduced by 20%. The random assignment of this study is assigned according to the order of assignment in the planning stage of the study as a block randomization scheme with appropriate block size set. - Plan for recruitment of research subjects All patients who underwent pancreaticoduodenectomy for the pancreas or peripapillary lesion were selected and selected as subjects after explaining the study and accepting consent. - Operative methods Both patients underwent conventional pancreaticoduodenectomy or pyloric preservation pancreaticoduodenectomy. In the control group, the midline incision was performed and the operation was performed by the laparotomy. In the experimental group, laparoscopic surgery was performed using 5-6 trocars. Laparoscopy and laparotomy are performed through the same surgical procedure and the procedure is as follows. Kocher maneuver is performed to mobilize the duodenum. Omentectomy is performed and the gastrocolic truck is identified and ligated. The stomach or duodenum is cut off using an automatic stapler. A cholecystectomy is performed. The bile duct is cut and the frozen section is checked to confirm whether the tumor is invaded. The hepatic and hepatic arteries are dissected and the surrounding lymph nodes are dissected. The gastroduodenal artery is detached and ligated. The pancreas is cut from the pancreas neck, and the tumor is examined by freezing biopsy. The proximal plant is dissected and cut, and the pancreas uncinate process is released from the superior mesenteric artery and vein. Pancreaticojejunal anastomosis, hepaticojejunal anastomosis, gastrojejunal or duodenojejunal anastomosis are performed. In this case, anastomosis is performed by the method used by each institution. Indications for open conversion - In a situation where the safety of the patient is threatened, it is possible to switch to the opener at any time under the judgment of the researcher. - Vascular involvement of the superior mesenteric vein, superior mesenteric artery, and hepatic artery is suspected and the operation is difficult to perform. - The operation is difficult due to severe pancreatitis - Laparoscopic treatment is difficult if there is bleeding Patient management after surgery. - 1 day after surgery: Removal of blood and nasogastric tube after surgery, water intake, early gait, cytokine check - 2 days after surgery: initiation or death, cytokine check - 3 days after surgery: intravenous patient controlled analgesia removal, after 3 days, considering drain amylase and drain volume can be removed. Check functional recovery daily after 3 days - 5 days after surgery: Perform computed tomography. - 7 days after surgery: If the patient is a malignant tumor, the tumor marker will be collected. Cytokine check


Recruitment information / eligibility

Status Completed
Enrollment 252
Est. completion date August 31, 2022
Est. primary completion date June 10, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 80 Years
Eligibility Inclusion Criteria: - Age: 19 to 80 years - Performance: Eastern Cooperative Oncology Group (ECOG) 0-2 - The preoperative examination showed that the lesion could not be invaded by major blood vessels. - No distant metastasis - Bone marrow function: white blood cell (WBC) at least 3,000 / mm3, Platelet count at least 100,000 / mm3 - Kidney function: Creatinine no greater than 1.5 times upper limit of normal. - Patients who consented to and signed the consent Exclusion Criteria: - Severe obesity (BMI> 30) - Those with active or uncontrolled infections - Those with severe psychiatric / neurological disorders - Alcohol or other drug addicts - Patients included in other clinical studies that may affect this study - Patients who cannot follow the directions of the researcher - Those with uncontrolled heart disease - Patients with moderate or severe comorbidities who are thought to have an impact on quality of life or nutritional status (cirrhosis, chronic kidney failure, heart failure, etc.) - Pelvic tumor, benign tumor, malignant tumor in other organs - Patients who received prior chemotherapy - In addition to the planned PD patients who require resection of other major abdominal organs (such as gastrectomy, colonic resection and portal / upper mesenteric vascular resection, more than standard PD)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic group
The patients in laparoscopic group will underwent pylorus preserving pancreaticoduodenectomy in laparoscopic manners.

Locations

Country Name City State
Korea, Republic of Asan medical center Seoul

Sponsors (5)

Lead Sponsor Collaborator
Asan Medical Center Hallym University Medical Center, Samsung Medical Center, Seoul National University Bundang Hospital, Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to functional recovery after surgery It is defined that functional recovery is achieved if all of the following are satisfied.
1. Pain can be controlled by oral or patch analgesic without intravenous analgesics. * 2. Free walking (modified enhanced recovery after surgery mobility scale 5/5) ** 3. Free diet is available (more than 1/2 of the dietary intake) 4. No evidence of infection (body temperature <38.5 degrees, C-reactive protein (CRP) 15 mg / dL, no complicated fluid collection on postoperative computed tomography 5. There should be no intravenous injection .
up to 1 months
Secondary Numbers of Hospital stay It is defined that discharge day after surgery up to 2 months
Secondary Minutes of operation time It mean time from anesthesia to end of surgery Up to 1 day after surgery
Secondary amount of estimated blood loss It means amount of bleeding during surgery up to 1 day after surgery
Secondary Severity of postoperative pain It refers to the degree of pain measured during 2 days after surgery Up to 3 days
Secondary postoperative complications It means all kinds of complications after surgery up to 2 months
Secondary Numbers of complete resection in pathological results It means no remnant tumor in pathologic results Up to 2weeks
Secondary level of serum cytokine It means value of serum cytokine, which was collected after surgery Up to 1 week
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04515485 - A Volumetric Nomogram for Height, Weight, and Intra Abdominal Volume
Completed NCT01725477 - Laparoscopic Tubal Patency Assessment N/A
Recruiting NCT01093430 - Is the Anterior Superior Iliac Spine a Useful Landmark at Laparoscopy? N/A
Recruiting NCT01093079 - Laparoscopic Versus Open Partial Nephrectomy - Surgical and Oncological Outcomes N/A
Completed NCT00535990 - Minimally Invasive Surgery (MIS) Database for the Purpose of Research
Completed NCT01092013 - Comparative Evaluation of Simulator Based and Traditional In-surgery Laparoscopic Camera Training's Efficiency in Novices N/A
Recruiting NCT06044909 - Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance
Completed NCT06255080 - Comparing Skills Acquisition on Different Laparoscopy Software N/A
Not yet recruiting NCT05389241 - Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial N/A
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Recruiting NCT02827292 - Effect of Music on Inflammatory Response During Laparoscopic Surgery N/A
Not yet recruiting NCT06092684 - The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery Phase 3
Terminated NCT01008709 - Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery N/A
Active, not recruiting NCT05363813 - Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery N/A
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Recruiting NCT05031182 - Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique. N/A
Active, not recruiting NCT05302622 - Detecting the Most Efficient Residency Time for Laparoscopic Simulators N/A
Recruiting NCT03684291 - Hemodynamic Effects of Ventilation Modes
Recruiting NCT06117748 - Volume-Controlled Ventilation and Pressure-Controlled Ventilation Volume Guaranteed in Obese Patients in Laparoscopic-Assisted Surgery N/A
Recruiting NCT03739944 - Different Surgical Approaches in Patients of Early-stage Cervical Cancer Phase 3